Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
ALK-positive and ROS1-positive metastatic Non-Small Cell Lung Cancer.
ALK-positive and ROS1-positive metastatic Non-Small Cell Lung Cancer.
Targeted treatment of solid tumors and hematologic malignancies.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Brain Tumors (Glioblastoma, Astrocytoma), Multiple Myeloma, Lymphomas, Leukemias, Sarcomas, and conditioning regimens.
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Approved for use in oncology care according to FDA-approved indications.
ALK-positive and ROS1-positive metastatic Non-Small Cell Lung Cancer.
Colorectal Cancer, Non-Small Cell Lung Cancer, Glioblastoma, Renal Cell Carcinoma, Gastric Cancer, and Ovarian Cancer.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.